Oberweis Asset Management Inc Legend Biotech Corp Transaction History

Oberweis Asset Management Inc

  • $1.57 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$55.06 - $69.99 $550,600 - $699,900
-10,000 Reduced 62.5%
6,000 $336,000
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $252,640 - $306,000
4,000 Added 33.33%
16,000 $1.07 Million
Q2 2023

Aug 14, 2023
BUY
$46.28 - $75.01 $555,360 - $900,120
12,000 New
12,000 $828,000

Others Institutions Holding LEGN

# of Institutions
212
Shares Held
77.9M
Call Options Held
412K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email